Leaps by Bayer(@LeapsByBayer) 's Twitter Profileg
Leaps by Bayer

@LeapsByBayer

Breaking through the impossible in the life sciences. Leaps by Bayer aims to conquer 10 huge challenges facing humanity.

ID:925767482912182274

linkhttps://leaps.bayer.com calendar_today01-11-2017 16:52:22

1,1K Tweets

33,1K Followers

168 Following

Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

🔍 Advances in Genetics: Hundreds of thousands of people in the US alone could receive a diagnosis years before symptoms appear, allowing for earlier and potentially more effective interventions.

Read more: nytimes.com/2024/05/06/hea…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

🔬 A unique enzyme found in enables them to efficiently capture CO2. Crucial for Earth's , these microorganisms could inspire crops, transforming agriculture. 🌱🌍
Read more: phys.org/news/2024-05-s…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Gene-editing advances promise to combat diverse diseases beyond rare ones. New tools like CAST systems might allow cutting and pasting of large pieces of , addressing complex diseases, and smaller Cas nucleases might offer safer and easier delivery: bit.ly/3K5gSlu

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

🌱 Climate solutions face hurdles. Florida's cultured meat ban limits progress. Livestock emissions, esp. beef, are significant. Let's embrace sustainable choices and support innovation. 🌍🍽

Read more: technologyreview.com/2024/05/07/109…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

🎉Exciting news! Senti Biosciences starts patient dosing in Phase 1 trial of SENTI-202 for hematologic malignancies like AML. Potential game-changer in cancer treatment! 🚀
Read more: investors.sentibio.com/news-releases/…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

'Who would have thought that gene therapy could restore hearing within a year? 👶 👂 🧬
Recent advancements in are reshaping the landscape of treatment, offering hope to families worldwide. Read more: fiercebiotech.com/biotech/little…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Modern is evolving with precision, thanks to groundbreaking technologies.
🧬 ✂️ 🌿
The review outlines the advancements in the field, covering technical innovation, and future research perspectives and challenges. More: phys.org/news/2024-04-a…

Modern #cropbreeding is evolving with precision, thanks to groundbreaking #geneediting technologies. 🧬 ✂️ 🌿 The review outlines the advancements in the field, covering technical innovation, and future research perspectives and challenges. More: phys.org/news/2024-04-a…
account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

The dawn of therapeutic . 🔬 Discover the innovative potential of this emerging field, with the help of captivating infographics from a recent article in Nature. 💉

nature.com/articles/d4158…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Exciting times ahead in biotech! 🔬 Check out this op-ed by Eric Schmidt on the imminent moment in . Explore how is reshaping the biotech landscape, accelerating , and transforming as we know it:

time.com/6967625/we-nee…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

🎉 AMR Action Fund and its portfolio company Utility Therapeutics received approval of Pivya, the first drug in approx. 20 years approved for U.T.I.s. U.T.I.s annually affect 30 million Americans. 💊 nytimes.com/2024/04/24/hea…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

From treatment to crops, is at the forefront of a revolution, offering solutions to pressing global challenges. 🧬✨
Explore CRISPR's transformative power in this article by World Economic Forum: weforum.org/agenda/2024/04…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Which technology will prevail as we transition away from fossil fuels? Leaps CEO Juergen Eckhardt explores the essential role play in our and mentions Leaps portfolio company CoverCress Inc. in his latest Forbes op-ed. 🌾

Μore: forbes.com/sites/juergene…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

For the first time, a person with is undergoing a revolutionary treatment that could potentially spawn a miniature liver within their lymph node, a temporary solution until a suitable donor organ becomes available. Read more :
nature.com/articles/d4158…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

This groundbreaking -T-based therapy for , dubbed 'CAR-TEAM' cells, embodies the spirit of innovative and unwavering dedication, representing a significant advancement in and tumor therapies. Read more: news.harvard.edu/gazette/story/…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

📣 news: Atomwise's platform AtomNet is redefining what's possible in and opens doors to unprecedented opportunities in developing first-in-class and best-in-class therapies with a 74% success rate. 🔬

More: drugdiscoverytrends.com/why-atomwise-s…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

📣 news: CoverCress Inc. just won BloombergNEF Pioneers 2024 award in 'Creating net-zero fuels' category.🏆 Congratulations, CoverCress Inc., your commitment to is admirable. Thank you for leading the way! 🌏👏
bit.ly/3xuvI1M

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Exciting news! A genetically modified pig kidney transplant offers hope for many. 62-year-old recipient leaves hospital after successful procedure, marking a major step forward in organ transplants: bit.ly/3U5Uiiy

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

is revolutionizing : Researchers Stanford Medicine just unveiled , a revolutionary model for discovery. 💊 They are now testing 6 novel drugs that can kill one of the most deadly bacteria. 📰 More: med.stanford.edu/news/all-news/…

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

Why are some diseases so difficult to treat? 🎯 Precision is key - that's where come in.These tiny molecules target disease-causing proteins with pinpoint accuracy, offering a new frontier in & . More in Juergen Eckhardts new op-ed: bit.ly/43SFDub

account_circle
Leaps by Bayer(@LeapsByBayer) 's Twitter Profile Photo

The first two cell-based for treating disease, Casgevy and Lyfgenia, were approved in December by the .

Learn about the and technologies like can bring for and : bit.ly/3x6v22o

account_circle